Taiwan Biotech Delegation Heads to BIO 2026 to Advance Global Partnerships and Innovation
Taiwan pavilion to present 40+ technologies from 33 companies at the world's largest biotechnology convention
SAN DIEGO, June 22, 2026 /PRNewswire/ -- Taiwan is showcasing the strength of its biotechnology ecosystem at BIO International Convention 2026 in San Diego from June 22–25, bringing together 33 biotechnology companies and more than 40 innovative technologies as it seeks to deepen global partnerships, attract investment and reinforce its position as one of Asia's leading biotechnology hubs.
Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) and supported by Taiwan's Ministry of Economic Affairs and other government agencies, the Taiwanese delegation will feature advancements spanning drug development, precision medicine, Contract Development and Manufacturing Organization (CDMO) services, biomanufacturing and digital health at the Taiwan Pavilion (Booth #2621).
Guided by the theme "Taiwan, Your Best Partner in Asia," Taiwan is building on the strong engagement and partnerships forged at BIO 2025 and leveraging BIO 2026 as a launchpad to showcase its thriving innovation ecosystem, deepen strategic collaborations, and unlock new opportunities in licensing, co-development, manufacturing collaboration and investment.
Taiwan at BIO 2026: Key Events & Engagement Opportunities
Taiwan's Biotech Industry Surpasses NT$1 Trillion in Market Value Amid IPO Boom
Taiwan's presence at BIO 2026 reflects the strength of its rapidly growing biotechnology sector. According to the 2025 Biotechnology Industry in Taiwan white paper, the industry generated a record NT$775.4 billion (US$25 billion) in revenue in 2024 and comprised 147 listed and over-the-counter biotech companies with a combined market value exceeding NT$1.47 trillion, underscoring Taiwan's position as one of Asia's leading biotechnology hubs.
"BIO 2026 offers an important opportunity for Taiwan's biotech industry to demonstrate its manufacturing capabilities, connect with global partners and explore new avenues for collaboration," said Michael Huang, Director of BPIPO. "We look forward to advancing healthcare innovation together with industry stakeholders worldwide."
As BIO 2026 brings together biotechnology leaders, investors, and industry stakeholders from around the world, Taiwan's participation provides an important platform for deepening international partnerships and accelerating cross-border collaboration. By showcasing its manufacturing capabilities, commercial-ready technologies and partnership opportunities, Taiwan aims to support the development of new technology partnerships, licensing agreements and clinical collaborations, while advancing its role in the global healthcare and life sciences ecosystem.
About BPIPO
The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) supports the growth and internationalization of Taiwan's biomedical sector by fostering innovation, industry collaboration and global partnerships. For more information, please visit BPIPO's website.
View the BravoTaiwan delegation list or discover more at www.bravotaiwan.cc
Domain
Company Name
Company Introduction
Biologics
AcadeMab Biomedical
Transforming Cancer Care & Next-Generation Vaccines
ACRO Biomedical
Make the impossible POSSIBLE.
Animmune Biotechnology
Rooted in Heritage, Rising in Innovation: Defining the Future of Animal Health.
PharmaEssentia
A fully-integrated biopharmaceutical company developing best-in-class therapies.
PlasmonicTron
PlasmonicTron standardizes large human 3D organoid production for industrial NAMs.
Taiwan Universe BioMedicine
Taiwan's biotech innovator pioneering next-gen vaccines for global health.
Biotech
Acer
Breaking barriers between people and technology.
Bened Biomedical
Fulfill the unmet neurological voids with novel neurobiotics
Coherence Biotech
Continuous lab automation for trusted multi-day cell and organoid experiments.
Ever Supreme Bio Technology
Pioneering cell therapy breakthroughs to improve health and quality of life worldwide.
Far East Bio-Tec.
Far East Bio-Tec develops microalgae derived APIs, antivirals, and drug delivery nanocarrier.
Health Ever Bio-Tech
HEB is a biotech company specializing in the R&D of new drugs for urological disorders.
Leadgene Biosolutions
Patented 96/24-well mixing and real-time DO, pH, OCR & ECAR monitoring for cell culture.
NanoRay Biotech
NanoRay Biotech develops new-generation X-ray tubes for medical imaging and tumor therapy.
OBI Pharma
OBI Pharma advances precision medicine with next-generation ADCs powered by Obrion®.
Precisemab Biotech
Precisemab develops Antibody Lock technology for safer, disease-site antibody activation.
TAHO Pharma
Innovating Drug Delivery for Better Patient Outcomes.
TCM Biotech International
We care about women's health and are developing a promising new drug for recurrent UTI.
TLC BioSciences
Lipid nanoparticle technology platform company advancing pain (Ph3), GLP-1, and CAR-T programs.
Vacino Biotech
The best brain delivery company.
CDMO
/ Contracted Service
Pharmigene
Pioneer precision medicine through advanced diagnostic solutions and patented pharmacogenomic tests.
SCIWIN Laboratories
SciWin Laboratories provides custom synthesis, CRO, CMO, and CDMO services.
Simpson Biotech
A biofermentation company for natural ingredients & recombinant proteins OEM.
Taiwan Bio-Manufacturing
A pure-play CRDMO providing GMP solutions for mRNA, cell therapy, viral vectors & complex biologics.
Taiwan Contract Research One-Stop Service
T.CROSS: Innovating Forward, Building a New Preclinical Service Ecosystem in Taiwan.
Yung Shin Pharm. Ind.
20+ years of FDA/PMDA compliance, delivering premium CMO/CDMO pharmaceutical services worldwide.
Medical Device
BloodScan Biotech
Building the blood test for every cancer visit!
Precision Health
AB DigiHealth
Achieving IVF success through innovation and science.
Anivance AI
Anivance AI builds human validation infrastructure for AI-driven drug development.
CancerFree Biotech
Biotech Organoid intelligence platform: patient-derived tumor models and AI-automated lab workflows.
Instant NanoBiosensors
Instant NanoBiosensors (INB) provides protein biomarker platforms and integrated NGS solutions.
Small Molecule Drug
AnnJi Pharmaceutical
AnnJi is a clinical-stage NCE drug developer for neglected neuro, derma and rare diseases
Dasher Neuroscience
Dasher Neuroscience, a late-clinical-stage biotech, uses AI to accelerate CNS therapies.
Gilva Therapeutics
Gilva is aimed to be a worldwide novel small molecule drug provider.
SOURCE BPIPO